Randomized phase II study of three doses of oral TAS-108 in postmenopausal patients with metastatic breast cancer.
Inaji H, Iwata H, Nakayama T, Yamamoto N, Sato Y, Tokuda Y, Aogi K, Saji S, Watanabe K, Saito T, Yoshida M, Sato N, Saeki T, Takatsuka Y, Kuranami M, Yamashita H, Kikuchi A, Tabei T, Ikeda T, Noguchi S.
Inaji H, et al.
Cancer Sci. 2012 Sep;103(9):1708-13. doi: 10.1111/j.1349-7006.2012.02354.x. Epub 2012 Jul 16.
Cancer Sci. 2012.
PMID: 22676245
Free PMC article.
Clinical Trial.